The organic industry’s GMO hoax

[pnwmom]

131. There should be such a requirement for the pharmaceutical industry, too, and any other industry

producing novel products that humans ingest or breathe into their lungs.

Recently, U.W. has admitted to the large amount of pharmaceutical research that is going unpublished because it isn't favorable to the drug companies.

http://www.seattletimes.com/seattle-news/health/study-uw-is-among-medical-centers-with-poor-clinical-trial-reporting-rates/

Leading academic medical centers across the U.S. — including the University of Washington and the Oregon Health & Science University (OHSU) — have a poor record of reporting results from clinical trials, leaving patients and doctors with a potentially skewed view of the safety and benefits of treatments, a new study finds.

Nationwide, only about two-thirds of results from more than 4,300 studies completed between 2007 and 2010 were published or reported — and only about one-third were released to the public within two years of completion.


Northwest institutions fared either about the same or worse, according to a new analysis published Wednesday in the journal BMJ.

“Once you realize that human experiments are being done and the results are not being reported, you realize that the entire scientific enterprise is being threatened,” said Dr. Harlan Krumholz, the Yale School of Medicine cardiologist and health-care researcher who led the study.

SNIP